Studying copy number variations using a nanofluidic platform
Data up to Jan 2025
Total Citations Per Year
Abstract
References (54)
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
1987 • 11,429 citations
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 • 11,070 citations
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 • 6,734 citations
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
2005 • 4,901 citations
Global variation in copy number in the human genome
2006 • 4,228 citations
Detection of large-scale variation in the human genome
2004 • 2,876 citations
Large-Scale Copy Number Polymorphism in the Human Genome
2004 • 2,542 citations
Structural variation in the human genome
2006 • 1,980 citations
Digital PCR
1999 • 1,585 citations
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
2007 • 1,508 citations
The essence of SNPs
1999 • 1,316 citations
USE OF CHEMOTHERAPY PLUS A MONOCLONAL ANTIBODY AGAINST HER2 FOR METASTATIC BREAST CANCER THAT OVEREXPRESSES HER2
2009 • 1,262 citations
Mapping and sequencing of structural variation from eight human genomes
2008 • 1,132 citations
Segmental Duplications and Copy-Number Variation in the Human Genome
2005 • 955 citations
The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
2007 • 894 citations
Pharmacogenetics and adverse drug reactions
2000 • 605 citations
Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.
1996 • 564 citations
A Comprehensive Analysis of Common Copy-Number Variations in the Human Genome
2006 • 521 citations
Methods and strategies for analyzing copy number variation using DNA microarrays
2007 • 510 citations
ERBB2 oncogene in human breast cancer and its clinical significance
1998 • 457 citations
Genomic rearrangements and sporadic disease
2007 • 423 citations
Digital PCR for the molecular detection of fetal chromosomal aneuploidy
2007 • 410 citations
The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
1989 • 407 citations
Challenges and standards in integrating surveys of structural variation
2007 • 393 citations
High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array
2008 • 368 citations
Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus
2004 • 344 citations
Recent duplication, domain accretion and the dynamic mutation of the human genome
2001 • 332 citations
Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device
2008 • 284 citations
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.
1991 • 273 citations
Overview of enzymes of drug metabolism
1996 • 270 citations
Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 gene
1996 • 198 citations
Nanoliter scale PCR with TaqMan detection
1997 • 194 citations
Two-fold differences are the detection limit for determining transgene copy numbers in plants by real-time PCR.
2004 • 161 citations
Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P
1990 • 156 citations
CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-rime PCR
2003 • 154 citations
The clinical role of genetic polymorphisms in drug-metabolizing enzymes
2007 • 138 citations
New Perspectives for the Elucidation of Genetic Disorders
2007 • 126 citations
CYP2D6 polymorphisms and the impact on tamoxifen therapy
2007 • 106 citations
Review article: the prevalence and clinical relevance of cytochrome P450 polymorphisms
2007 • 98 citations
Novel Real-Time Quantitative PCR Test for Trisomy 21
2002 • 87 citations
Prognostic and predictive value of HER2/neu oncogene in breast cancer
2002 • 84 citations
Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication
1998 • 79 citations
Recombining overlapping BACs into a single larger BAC.
2004 • 73 citations
Determination of Cytochrome P450 2D6 (CYP2D6) Gene Copy Number by Real‐Time Quantitative PCR
2005 • 70 citations
HER-2/neu Gene Copy Number Quantified by Real-Time PCR: Comparison of Gene Amplification, Heterozygosity, and Immunohistochemical Status in Breast Cancer Tissue
2003 • 65 citations
Individualized drug therapy.
2007 • 64 citations
Ongoing adjuvant trials with trastuzumab in breast cancer
2003 • 59 citations
Autosomal-Dominant Microtia Linked to Five Tandem Copies of a Copy-Number-Variable Region at Chromosome 4p16
2008 • 47 citations
HER2 testing: a review of detection methodologies and their clinical performance
2006 • 44 citations
Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6
2007 • 43 citations
Intracellular expression profiles measured by real-time PCR tomography in the Xenopus laevis oocyte
2007 • 34 citations
Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer
2006 • 27 citations
DNA amplification: current technologies and applications.
2004 • 27 citations
Clinical Implications of CYP2D6 Genetic Polymorphism During Treatment with Antipsychotic Drugs
2006 • 24 citations